Can Antidepressants Cause Acid Reflux? Which Ones Do

Some can — but the evidence is far more selective than most articles on this suggest, and the honest answer is more interesting than a list of culprits.

The theory is sound. Antidepressants with anticholinergic properties relax the lower oesophageal sphincter, slow the stomach’s emptying and reduce saliva production — three separate routes to reflux. But when researchers actually tested it in 1,462 people with endoscopy-confirmed reflux oesophagitis, the class-wide effect for tricyclics was modest, and drug-specific analysis found that only clomipramine was genuinely associated with reflux. No association was found for any other tricyclic.

There’s a bigger problem too, and it’s one that makes this question unusually hard to answer. Depression itself independently raises the risk of developing reflux — incidence of 14.2 per 1,000 person-years in people with depression against 8.3 in controls. So when someone on antidepressants develops reflux, disentangling the drug from the condition it’s treating is genuinely difficult.

And then the paradox: the same drug classes are used to treat oesophageal symptoms, with antidepressant therapy reducing heartburn in GERD patients by 23% to 61% in a systematic review.

Below is what’s actually established, which drugs are most likely to be a problem, and what to do about it. One thing first, because it matters more than anything else in this article.

Do not stop or reduce an antidepressant on your own. Stopping abruptly can cause discontinuation symptoms and risks relapse of the condition being treated, which is a considerably bigger problem than heartburn. If you think your medication is causing reflux, that’s a conversation with your prescriber — there are usually good options. This article is general information, not medical advice.

Key Takeaways

• Anticholinergic antidepressants can plausibly cause reflux by relaxing the lower oesophageal sphincter, delaying gastric emptying, slowing oesophageal clearance and reducing saliva.
• In a case-control study of 1,462 endoscopy-confirmed cases, current tricyclic users had a modestly raised risk of reflux oesophagitis (adjusted OR 1.61, 95% CI 1.04–2.50).
• Drug-specific analysis found only clomipramine was associated (adjusted OR 4.6, 95% CI 2.0–10.6), rising with dose and duration.
• No association was found between reflux oesophagitis and any tricyclic other than clomipramine — which undercuts the usual blanket claim.
• The study authors noted the clomipramine link might reflect the underlying condition rather than the drug.
• Depression itself raises reflux risk substantially (hazard ratio 1.72), making cause and effect hard to separate.
• Amitriptyline, clomipramine, imipramine, doxepin and paroxetine carry the highest anticholinergic load.
• Sertraline, escitalopram, citalopram and bupropion are among the least anticholinergic.
• Weight gain is an indirect but real route — mirtazapine, paroxetine and amitriptyline are the usual offenders.
• SSRIs combined with NSAIDs meaningfully raise upper gastrointestinal bleeding risk, which is worth knowing if you take ibuprofen too.

How an Antidepressant Could Cause Reflux

Four mechanisms, and they’re worth separating because they point to different drugs and different fixes.

1. Anticholinergic effects

This is the main one. Acetylcholine is the neurotransmitter that drives smooth muscle tone and glandular secretion throughout your gut. Drugs that block it — and many older antidepressants do — produce a predictable set of consequences:

• Lower oesophageal sphincter pressure falls. The valve between stomach and oesophagus relies partly on cholinergic tone. Reduce that and the barrier weakens. Background in the lower oesophageal sphincter and acid reflux.
• Gastric emptying slows. Food and acid sit in the stomach longer, which means more volume and more pressure for longer — see gastroparesis and acid reflux.
• Oesophageal peristalsis weakens. Once acid is up there, the muscular contractions that sweep it back down are less effective, so it stays in contact with the lining longer. More in oesophageal motility and acid reflux.
• Saliva production drops. This one is badly underappreciated. Saliva is bicarbonate-rich and neutralises acid in the oesophagus and throat — it’s a genuine defence mechanism, not an incidental fluid. Dry mouth is one of the commonest anticholinergic side effects, and it removes that protection. See saliva, bicarbonate and acid reflux and acid reflux and dry mouth.

Four hits at once, which is why anticholinergic burden is the single most useful thing to look at when assessing a drug on this list.

2. Serotonin and gut motility

Around 95% of the body’s serotonin sits in the gut, where it regulates motility and secretion. SSRIs raise serotonin availability, and the gut notices — nausea, indigestion and altered bowel habit are among the commonest early side effects, usually settling within a few weeks.

Whether that translates into reflux specifically is much less clear. The nausea and dyspepsia are well documented; a direct reflux effect isn’t. I’d treat this as a plausible contributor rather than an established one.

3. Weight gain

This is indirect but genuinely important and often overlooked. Several antidepressants cause weight gain — mirtazapine and paroxetine most notably, along with amitriptyline. Excess weight, particularly around the abdomen, raises intra-abdominal pressure and mechanically pushes stomach contents upward. It’s one of the most consistently supported risk factors for reflux, and guidelines specifically recommend weight loss for patients who are overweight Katz et al., The American Journal of Gastroenterology, 2022.

So a drug can cause reflux over months without ever touching your sphincter, purely through this route. If your reflux started a while after beginning treatment rather than immediately, weight is worth checking.

4. Direct pill irritation

Any tablet that lodges in the oesophagus can irritate the lining locally. It’s less of an issue with antidepressants than with some drugs, but the fix costs nothing: take tablets with a full glass of water and stay upright for half an hour, rather than swallowing them dry at bedtime.

What the Evidence Actually Shows

Here’s where the popular version of this topic falls apart, and it’s worth going through carefully.

A population-based case-control study was conducted in a large Dutch primary care database covering 1996 to 2005. Researchers identified 1,462 cases of endoscopy-confirmed reflux oesophagitis and matched each with up to ten controls on sex, age, GP practice and calendar time — a well-designed study with an objective endpoint rather than self-reported symptoms.

Current tricyclic users did have a raised risk: adjusted odds ratio 1.61, 95% CI 1.04 to 2.50. That’s a real but modest association, and it’s the number usually quoted.

But the drug-specific analysis is the interesting part. Only clomipramine showed an association — adjusted OR 4.6, 95% CI 2.0 to 10.6 — and it behaved exactly as a genuine drug effect should, rising with both duration (OR 7.1 for use beyond 180 days) and dose (OR 9.2 for more than one defined daily dose equivalent per day). The authors’ conclusion was explicit: no association was observed between reflux oesophagitis and the use of tricyclics other than clomipramine van Soest et al., The American Journal of Gastroenterology, 2007.

That’s a genuinely surprising result, because clomipramine isn’t the most anticholinergic tricyclic — amitriptyline and doxepin are comparable or higher. If the anticholinergic mechanism were doing the work, you’d expect those to show up too, and they didn’t.

The authors were careful about this themselves, noting the clomipramine association might be drug-related or a result of the underlying indication. Clomipramine is prescribed heavily for obsessive-compulsive disorder and severe anxiety, which are conditions with their own relationship to gut symptoms — so the drug may be flagging the patient rather than causing the problem.

My reading: the mechanism is real and biologically sound, but the population-level effect for most antidepressants is smaller than the internet implies. If you’re on amitriptyline and have reflux, this study offers no evidence that the drug caused it.

The Confounder That Complicates Everything

Any honest article on this has to deal with the fact that depression itself causes reflux.

In a UK primary care cohort study, the incidence of GERD was 14.2 per 1,000 person-years in people with depression against 8.3 per 1,000 person-years in controls — a hazard ratio of 1.72 (95% CI 1.60–1.85) Martín-Merino et al., Alimentary Pharmacology & Therapeutics, 2010.

That’s a substantial effect, and there are several plausible reasons for it. Stress and low mood alter gut motility and visceral sensitivity through the gut–brain axis — the mechanics are in the vagus nerve and acid reflux and can stress cause acid reflux. Depression also affects sleep, appetite, eating patterns, alcohol intake, smoking and activity levels, every one of which touches reflux. And people who are distressed report symptoms more readily, which inflates any symptom-based measure.

This creates a real interpretive problem. Almost everyone taking an antidepressant has a condition that independently raises reflux risk. Untangling drug from illness requires study designs that mostly haven’t been done, and it’s the honest reason the evidence here is thinner than you’d expect for such a commonly asked question.

The practical implication is a hopeful one, though. If depression and anxiety drive reflux, then successfully treating them may improve your reflux — and stopping your medication could make things worse rather than better. Which is one more reason not to do it unilaterally. Related reading in can LPR be caused by anxiety.

Which Antidepressants Are Most Likely to Be a Problem?

Ranked by anticholinergic burden and the other mechanisms above. This is based on the known pharmacology of the drugs rather than head-to-head reflux studies, which mostly don’t exist — so treat it as a guide to what to discuss with your prescriber, not a verdict on any particular drug.

Highest anticholinergic load — the tertiary amine tricyclics:

• Clomipramine — the only one with a specific reflux association in the evidence above.
• Amitriptyline — strongly anticholinergic and sedating, commonly causes dry mouth, and often taken at bedtime, which compounds the timing issue.
• Imipramine, doxepin, trimipramine — similar profile.

Moderate:

• Nortriptyline and desipramine — secondary amine tricyclics, meaningfully less anticholinergic than the group above and often the swap a prescriber will consider if the tricyclic itself is needed.
• Paroxetine — the most anticholinergic of the SSRIs, and among the most associated with weight gain.
• Mirtazapine — low anticholinergic activity but the most associated with weight gain and appetite increase, so the indirect route matters. It’s also sedating and taken at night.

Generally lower risk:

• Sertraline, escitalopram, citalopram, fluoxetine — minimal anticholinergic activity. Early nausea and indigestion are common but usually settle.
• Venlafaxine and duloxetine — nausea is frequent in the first weeks, less so later; low anticholinergic load.
• Bupropion — low anticholinergic activity and tends to be weight-neutral or weight-reducing.

Two caveats worth stating. Anticholinergic burden is cumulative across everything you take — antihistamines, bladder medications, some sleep aids and others all add to it, so an antidepressant may be the last straw rather than the sole cause. And individual response varies enormously; plenty of people take amitriptyline with no gut symptoms at all. The wider list of drug culprits is in medications that make acid reflux worse.

The Paradox: They’re Also Used as Treatment

Here’s where this topic becomes genuinely counterintuitive, and it’s the part that most articles miss entirely.

Antidepressants at low doses are an established treatment for oesophageal symptoms. Used this way they’re called central neuromodulators, and the dose is typically a fraction of what’s used for depression — they’re working on nerve signalling and pain perception, not mood.

A systematic review of antidepressants in patients with functional oesophageal disorders or GERD found antidepressant therapy reduced functional chest pain across a range of 18% to 67%, and reduced heartburn in GERD patients across a range of 23% to 61% Weijenborg et al., Clinical Gastroenterology and Hepatology, 2015. Later work has found the effect most convincing for functional chest pain and globus sensation, and less consistent for functional heartburn and reflux hypersensitivity specifically.

The mechanism is visceral hypersensitivity. In some people the oesophagus becomes over-sensitised, so normal or minimal amounts of acid produce disproportionate symptoms. That’s why some people have severe heartburn with a completely normal endoscopy, and why acid suppression sometimes fails to help — there isn’t much acid to suppress. Neuromodulators turn down the volume on that signalling.

So amitriptyline can, in principle, worsen reflux through anticholinergic effects and improve reflux symptoms through desensitisation — in different people, at different doses. That’s genuinely how it works, uncomfortable as it is for anyone wanting a clean answer. I’ve written about this use in amitriptyline and gabapentin for reflux cough, and the related nerve problem in laryngeal sensory neuropathy. If your main symptom is globus sensation, this is particularly relevant — that’s one of the symptoms neuromodulators help most.

SSRIs, NSAIDs and Bleeding Risk

A practical safety point that sits slightly outside reflux but matters if you’re managing both.

SSRIs reduce serotonin uptake into platelets, and platelets need serotonin to aggregate properly. The result is a mild impairment of clotting. On its own the absolute risk is small, but combined with an NSAID like ibuprofen — which independently damages the gut lining — the risks compound. Meta-analysis found the addition of an SSRI to NSAID therapy further raised the odds of upper gastrointestinal bleeding (OR 1.75, 95% CI 1.32–2.33) Alam et al., Scientific Reports, 2022.

This isn’t a reason to avoid either drug. It’s a reason to mention both to your pharmacist, to avoid casually reaching for ibuprofen for everyday aches while on an SSRI, and to ask whether gastroprotection is appropriate if you need both regularly.

What to Do If You Think Yours Is Causing Reflux

First, don’t stop it. Antidepressants need tapering. Stopping abruptly — particularly paroxetine and venlafaxine, which clear the body quickly — can cause discontinuation symptoms including dizziness, flu-like feelings, sleep disturbance and unpleasant electric-shock sensations. More importantly, it risks relapse of the condition being treated. Untreated depression is a far more serious problem than heartburn, and it may worsen your reflux anyway.

Work out whether the timing fits. Did the reflux begin within a few weeks of starting or increasing the dose? That’s suggestive. Did it appear a year in? More likely weight, or something else entirely. Keep a simple two-week diary of symptoms, meals, timing and any other medication — it makes the conversation with your doctor far more productive.

Then talk to your prescriber. The realistic options they may consider:

• Switching within the class — for instance a less anticholinergic tricyclic, or a different SSRI.
• Adjusting the dose — the clomipramine effect was dose-dependent, so lower may genuinely mean less.
• Changing the timing — a sedating antidepressant taken at bedtime coincides with lying flat. Taking it earlier isn’t always possible but is sometimes an easy win. See acid reflux at night.
• Adding gastroprotection — if the medication is genuinely needed and working.
• Reviewing your whole medication list for cumulative anticholinergic burden.

Meanwhile, work on everything else. The measures that help reflux generally still apply and are entirely within your control: finish eating two to three hours before bed, raise the head of your bed, manage weight, and consider an alginate for symptom relief — see alginates for acid reflux and how long before bed you should stop eating. If dry mouth is part of your picture, sipping water regularly and chewing sugar-free gum both stimulate saliva and are more useful than they sound.

Since stress and mood feed into reflux directly, non-drug approaches are doing double duty here. Diaphragmatic breathing exercises have reasonable evidence behind them for reflux specifically, and they’re free.

When to See a Doctor

Get medical advice promptly if you have:

• Difficulty or pain on swallowing, or food sticking
• Unintentional weight loss
• Vomiting blood, or vomit resembling coffee grounds
• Black, tarry stools
• Persistent vomiting
• Reflux symptoms that are new after age 50, or that don’t respond to treatment

More on investigation in endoscopy for acid reflux and when to see a doctor for LPR. And if your mood is worsening, or you’re considering stopping your medication because of side effects, please raise it with your doctor rather than managing it alone — that’s exactly the situation where a short conversation prevents a much larger problem.

Conclusion

Antidepressants can cause reflux, but the evidence is narrower and more specific than the blanket warnings suggest. The anticholinergic mechanism is real and well understood — a weaker sphincter, slower stomach emptying, sluggish oesophageal clearance and less protective saliva. Yet when it was tested properly against endoscopy-confirmed disease, only clomipramine stood out, and even the authors of that study wondered whether it was really the drug or the condition it treats.

The confounding is the part I’d want people to sit with. Depression itself raises reflux risk by roughly 70%, which means most people taking these drugs already had an elevated risk before the first tablet. That cuts both ways: your medication might be contributing, and it might equally be helping by treating something that was driving your symptoms in the first place.

What I’d actually do with this information is modest and practical. If your reflux began soon after starting a tricyclic or paroxetine, mention it to your prescriber — there are usually less anticholinergic alternatives. If it appeared gradually over a year, look at weight before blaming the drug. Check your whole medication list for cumulative anticholinergic load, not just the antidepressant. Be cautious about routinely combining an SSRI with ibuprofen. And do all the ordinary reflux things, which work regardless of what’s causing it.

What I wouldn’t do is stop the medication. That’s the one move with real downside risk, and it’s the one this kind of article most often prompts.

Whatever’s driving your symptoms, the day-to-day management still comes down to what and when you eat — and working out which foods genuinely need to go, which just need timing differently, and in what order to test them is most of the real work. That’s what the Wipeout Diet Plan is structured around, as a way of reducing reflux episodes rather than a list of prohibitions. I built it first and foremost for LPR and silent reflux, the stubborn throat-based form that responds worst to medication, though because it targets the same underlying mechanisms it works just as well for GERD and everyday heartburn. Alongside it, the Wipeout Food Reference Guide is the practical companion — the full list of foods and drinks that are safe for acid reflux and LPR with their actual pH values, so the parts you can control are working in your favour while you sort out the parts you can’t.

Frequently Asked Questions

Can antidepressants cause acid reflux?

Some can. Drugs with anticholinergic properties relax the lower oesophageal sphincter, slow gastric emptying, weaken oesophageal clearance and reduce protective saliva. But in the best available study, only clomipramine showed a clear association with endoscopy-confirmed reflux oesophagitis — no association was found for other tricyclics.

Which antidepressants are worst for acid reflux?

By anticholinergic load, the tertiary amine tricyclics: clomipramine, amitriptyline, imipramine, doxepin and trimipramine. Paroxetine is the most anticholinergic SSRI. Mirtazapine is low in anticholinergic activity but the most associated with weight gain, which raises reflux risk indirectly.

Which antidepressants are least likely to cause reflux?

Sertraline, escitalopram, citalopram and fluoxetine have minimal anticholinergic activity. Bupropion is low-anticholinergic and tends to be weight-neutral. Nortriptyline and desipramine are meaningfully less anticholinergic than the older tricyclics if a tricyclic is needed. Your prescriber will weigh this against what actually works for you.

Does amitriptyline cause acid reflux?

It’s strongly anticholinergic, so it plausibly can — but the case-control evidence found no association between amitriptyline and reflux oesophagitis, only clomipramine. Complicating things further, low-dose amitriptyline is itself used to treat oesophageal hypersensitivity and reflux cough. Individual response varies a lot.

Can SSRIs cause acid reflux?

Nausea and indigestion are common in the first few weeks and usually settle. A specific reflux effect is less well established, since SSRIs have little anticholinergic activity apart from paroxetine. Weight gain on some SSRIs is a more plausible indirect route over the longer term.

How long after starting an antidepressant would reflux appear?

Anticholinergic effects begin within days to a couple of weeks, so a drug-related sphincter or saliva effect usually shows up early. Reflux that appears months later is more likely mediated by weight gain or something unrelated. That timing distinction is genuinely useful diagnostically.

Should I stop my antidepressant if it’s causing heartburn?

No — not on your own. Stopping abruptly can cause discontinuation symptoms and risks relapse, which is a much bigger problem than heartburn. Speak to your prescriber; switching drug, adjusting dose or timing, or adding gastroprotection are all options that keep your treatment intact.

Does depression itself cause acid reflux?

Yes, independently of medication. In a large primary care cohort, GERD incidence was 14.2 per 1,000 person-years in people with depression versus 8.3 in controls — a hazard ratio of 1.72. Stress affects gut motility and visceral sensitivity, and depression also changes sleep, eating patterns and activity levels.

Why is amitriptyline prescribed for reflux if it can cause it?

Different dose, different target. At low doses it acts as a central neuromodulator, reducing the oesophagus’s sensitivity to acid rather than reducing acid itself. That helps people whose problem is hypersensitivity rather than excess acid — which is why it’s used for reflux cough, functional chest pain and globus.

Is it safe to take ibuprofen with an SSRI?

Occasionally, for most people, but the combination raises the risk of upper gastrointestinal bleeding more than either drug alone — SSRIs impair platelet function while NSAIDs damage the gut lining. If you need regular pain relief, ask your pharmacist about paracetamol or a topical NSAID gel instead.

Research & References

• van Soest et al., The American Journal of Gastroenterology, 2007 — Population-based case-control study in a large Dutch primary care database covering 1996–2005, identifying 1,462 cases of endoscopy-confirmed reflux oesophagitis matched with up to 10 controls each on sex, age, practice and calendar time. Risk of reflux oesophagitis was increased in current tricyclic antidepressant users (adjusted OR 1.61, 95% CI 1.04–2.50). Drug-specific analysis found only clomipramine associated with increased risk (adjusted OR 4.6, 95% CI 2.0–10.6), in a duration- and dose-dependent manner (OR 7.1 for use beyond 180 days; OR 9.2 for more than 1 DDD equivalent per day). No association was observed for tricyclics other than clomipramine, and the authors noted the association might be drug-related or a result of the underlying indication.
• Martín-Merino et al., Alimentary Pharmacology & Therapeutics, 2010 — Cohort study in UK primary care data examining depression, antidepressant treatment and the development of gastro-oesophageal reflux disease. GERD incidence was 14.2 per 1,000 person-years in the depression cohort compared with 8.3 per 1,000 person-years in controls, giving a hazard ratio of 1.72 (95% CI 1.60–1.85).
• Weijenborg et al., Clinical Gastroenterology and Hepatology, 2015 — Systematic review of the effects of antidepressants in patients with functional oesophageal disorders or gastro-oesophageal reflux disease. Antidepressant therapy reduced functional chest pain across a range of 18% to 67% and reduced heartburn in patients with GERD across a range of 23% to 61%, with visceral hypersensitivity proposed as the mechanism modulated by treatment.
• Alam et al., Scientific Reports, 2022 — Systematic review and meta-analysis of selective serotonin reuptake inhibitors and upper gastrointestinal bleeding risk. Concomitant SSRI use in patients taking NSAIDs was associated with a further increased risk of upper gastrointestinal bleeding (OR 1.75, 95% CI 1.32–2.33), attributed to SSRI-related impairment of platelet aggregation and haemostasis.
• Katz et al., The American Journal of Gastroenterology, 2022 — ACG clinical guideline for the diagnosis and management of gastro-oesophageal reflux disease, which recommends weight loss for patients who are overweight, suggests avoiding meals within 2 to 3 hours of bedtime, and suggests avoiding individual trigger foods as a conditional recommendation on low-quality evidence.